Skip to main content

Advertisement

Log in

Acceptance of neoadjuvant short-term radiotherapy: a survey under surgeons and radiotherapists

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background and aims

Since introduction of total mesorectal excision (TME) the prognosis of rectal cancer patients has improved significantly. Debate exists regarding the optimal mode of multimodal treatment. The aim of this survey was to determine the preferred multimodal treatment and the significance and acceptance of short-term radiotherapy (5 × 5 Gy) in Germany.

Methods

In August 2003, a questionnaire was sent to the heads of all 1,275 surgical and 157 radiotherapy departments in Germany.

Results

Four hundred ninety-three of 1,275 surgical (39%) and 89 of 157 radiotherapeutic questionnaires (56%) were returned. The majority of the answering surgeons and radiotherapists performed adjuvant (89 and 100%), followed by neoadjuvant (61 and 94%) and short-term radiotherapy (5 × 5 Gy) (16 and 17%). Other questions of the survey dealt with indications for each treatment modality, the initiation of treatment, and reasons for objection to short term radiotherapy.

Conclusion

Short-tem radiotherapy played a minor role in the treatment of rectal cancer patients in 2003 and was mainly initiated by surgeons (∼70%). However, 74% of the answering surgeons and 42% of the answering radiotherapists not performing short-term radiotherapy in 2003 were open minded towards the introduction of this treatment modality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Boyle P (1998) Some recent developments in the epidemiology of colorectal cancer. In: Bleiberg H, Rougier P, Wilke HJ (eds) Management of colorectal cancer. Martin Dunitz, London, p 19–34

    Google Scholar 

  2. Hermanek P, Wiebelt H, Staimmer D, Riedl S, German study group colorectal carcinoma (1995) Prognostic factors of rectum carcinoma-experience of the German multicentre study SGCRC. Tumori 81(3 Suppl):60–64, (May)

    PubMed  CAS  Google Scholar 

  3. Rodel C, Hohenberger W, Sauer R (1998) Adjuvant and neoadjuvant therapy of rectal carcinoma. The current status. Strahlenther Onkol 174(10):497–504, (October)

    Article  PubMed  CAS  Google Scholar 

  4. Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg 69(10):613–616, (October)

    Article  PubMed  CAS  Google Scholar 

  5. Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1(8496):1479–1482, (June 28)

    Article  PubMed  CAS  Google Scholar 

  6. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345(9):638–646, (August 30)

    Article  PubMed  CAS  Google Scholar 

  7. Marijnen CA, Kapiteijn E, van d, V, Martijn H, Steup WH, Wiggers T, Kranenbarg EK, Leer JW (2002) Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 120(3):817–825, (February)

    Article  Google Scholar 

  8. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731–1740, (October 21)

    Article  PubMed  CAS  Google Scholar 

  9. Stockholm rectal cancer study group (1990) Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer 66(1):49–55, (July 1)

    Article  Google Scholar 

  10. Pollack J, Holm T, Cedermark B, Altman D, Holmstrom B, Glimelius B, Mellgren A (2006) Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg 93(12):1519–1525, (December)

    Article  PubMed  CAS  Google Scholar 

  11. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93(10):1215–1223, (October)

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jürgen Weitz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ulrich, A., Schwerdt, J., Z`graggen, K. et al. Acceptance of neoadjuvant short-term radiotherapy: a survey under surgeons and radiotherapists. Langenbecks Arch Surg 392, 525–533 (2007). https://doi.org/10.1007/s00423-006-0139-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-006-0139-0

Keywords

Navigation